In recent years, with the upgrading of the pet health industry, natural herbal ingredients have received much attention in the field of
Pet Nutritional Supplements. Among them, Ganoderma Lucidum and Rhodiola Rosea, as star ingredients in traditional Chinese medicine, are being combined using modern biotechnology to produce a synergistic effect in pet nutritional supplements. Henan Yipai Biotechnology Co., Ltd. has launched a series of pet nutritional oral liquids, which for the first time combine these two ingredients and apply them to the field of
Veterinary supplements, providing new ideas for pet health management.
Scientific Formulation Mechanism of Core Ingredients
According to Henan Yipai Biotechnology's product information, its Rhodiola Rosea amino peptide oral liquid series all use a compound formulation of "Ganoderma Lucidum extract + Rhodiola Rosea extract + spleen amino peptide". Reishi mushroom is rich in polysaccharides and triterpenoids, which can enhance immunity, combat fatigue, and protect the liver; Rhodiola rosea excels at combating hypoxia, combating fatigue, and regulating blood lipids. These two are combined using small molecule peptide technology to form a
Pet Ganoderma Nutritional Supplement, which simultaneously acts on the immune, energy metabolism, and antioxidant systems.
Technological Breakthrough: Fresh Meat Enzymatic Hydrolysis Improves Bioavailability
Henan Yipai Biotechnology Co., Ltd. uses fresh meat enzymatic hydrolysis technology to convert the effective components of Reishi mushroom and Rhodiola rosea into more easily absorbed small molecule peptides. For example, in Yi A peptide oral liquid, the
Ganoderma Oil Pet Nutrition component enhances the absorption efficiency of fat-soluble vitamins through lipid carriers, while the glycosides in Rhodiola rosea improve stability through peptide chain coupling. This process increases the bioactivity of
Reishi Mushroom for Pets by approximately 30% and effectively avoids the problem of poor palatability for pets compared to traditional herbs.
Clinical Validation: Synergistic Effects Across Multiple Systems
In experiments targeting sub-health conditions in pets, the compound formula demonstrated advantages not found in single-component formulations:
* **Immune Regulation:** Ganoderma lucidum polysaccharides activate macrophages, while Rhodiola rosea alleviates stress-induced immunosuppression by regulating the hypothalamic-pituitary-adrenal axis.
* **Energy Metabolism:** Rhodiola rosea improves mitochondrial function, and Ganoderma lucidum triterpenoids promote ATP synthesis, jointly addressing the decline in pet activity levels.
* **Antioxidant Network:** Ganoderic acids and rhodiolosides in Rhodiola rosea form a free radical scavenging chain reaction, delaying cell aging.
**Market Application Prospects for Veterinary Supplements:** Currently, this product series has undergone clinical validation in multiple animal hospitals, including Hefei Ruipeng Pet Hospital and Shenyang Chongyisheng. For scenarios such as post-operative recovery and chronic disease management in senior pets, veterinary supplements provide personalized nutritional support through a combination of traditional Chinese and Western medicine. For example, in the adjunctive treatment of respiratory diseases, the anti-inflammatory properties of Ganoderma lucidum complement the anti-hypoxia effects of Rhodiola rosea.
With the increasing popularity of the "prevention is better" concept for pets, the combination of traditional Chinese medicine natural ingredients with current nutritional science will become an important direction for pet nutrition product research and development. Henan Yipai Biotechnology stated that its Ganoderma lucidum molecular peptide series has obtained an invention patent (patent number 202110933638.0), and in the future, it will deepen research on the synergistic mechanism between Rhodiola rosea and other adaptable herbs and Ganoderma lucidum, promoting the upgrade of pet nutrition from "single supplementation" to "systemic regulation."
